Your fact-checks

Your fact-checks will appear here

factually
Support us
  • Home
  • Politics
  • Business
  • Society
  • Technology
  • Health
  • Science
  • Entertainment
Index/Topics/Aducanumab controversy

Aducanumab controversy

Aducanumab (Aduhelm®) controversy over clinical benefit and regulatory standards

Fact-Checks

1 result
Jan 7, 2026

What are the FDA‑approved treatments for Alzheimer’s and what do they do?

The FDA now recognizes two classes of treatments for Alzheimer’s: disease‑modifying, amyloid‑targeting monoclonal antibodies that can modestly slow clinical decline in early disease, and older symptom...

About
Blog
Contact
FAQ
Terms & ConditionsTerms
Privacy PolicyPrivacy
Manage data